SEC Form D · filed June 1, 2020
SQZ Biotechnologies Co
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Armon Sharei, Ph.D · WATERTOWN, MAExec · DirectorEric W. Moessinger · WATERTOWN, MADirectorTeri W. Loxam · Watertown, MAExecZafrira W. Avnur · Watertown, MADirectorKlavs F. Jensen, Ph.D · WATERTOWN, MADirectorHoward W. Bernstein, M.D., Ph.D · Watertown, MAExecOliver W. Rosen, M.D · Watertown, MAExecDavid W. First · Watertown, MAExecAlexandra W. Balcom · Watertown, MAExecPushkal W. Garg · Watertown, MADirectorMarc W. Elia · Watertown, MADirectorLawrence W. Knopf · Watertown, MAExecAmy W. Schulman · Cambridge, MADirectorJonathan Fleming · Lexington, MADirectorHoward W. Bernstein, M.D., Ph.D · Watertown, MAExecOliver W. Rosen, M.D · Watertown, MAExecDavid W. First · Watertown, MAExecArmon Sharei, Ph.D · WATERTOWN, MAExec · DirectorEric W. Moessinger · WATERTOWN, MADirectorAlexandra W. Balcom · Watertown, MAExecTeri W. Loxam · Watertown, MAExecPushkal W. Garg · Watertown, MADirectorMarc W. Elia · Watertown, MADirectorZafrira W. Avnur · Watertown, MADirectorLawrence W. Knopf · Watertown, MAExecKlavs F. Jensen, Ph.D · WATERTOWN, MADirectorAmy W. Schulman · Cambridge, MADirectorJonathan Fleming · Lexington, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗